Severity: Warning
Message: fopen(/var/lib/php/sessions/ci_sessionach8cti2178klr0k0iacptp6i77has79): Failed to open stream: No space left on device
Filename: drivers/Session_files_driver.php
Line Number: 177
Backtrace:
File: /var/www/html/index.php
Line: 316
Function: require_once
Severity: Warning
Message: session_start(): Failed to read session data: user (path: /var/lib/php/sessions)
Filename: Session/Session.php
Line Number: 137
Backtrace:
File: /var/www/html/index.php
Line: 316
Function: require_once
17 results match your criteria: "Romagna Cancer Institute (IRST) IRCCS[Affiliation]"
G Ital Dermatol Venereol
December 2020
Romagna Cancer Registry, Romagna Cancer Institute (IRST) IRCCS, Meldola, Forlì-Cesena, Italy, The originally published version of this article is available online at https://www.doi.org/10.23736/S0392-0488.17.05584-5.
This corrects the article DOI: 10.23736/S0392-0488.17.
View Article and Find Full Text PDFEur J Cancer
November 2017
ISPO - Cancer Research and Prevention Institute, Clinical Epidemiology, Florence 50141, Italy. Electronic address:
J Gynecol Oncol
July 2017
Department of Obstetrics and Gynecology, University of Torino, Torino, Italy.
Objective: To evaluate the prevalence and risk factors for unrecognized invasive carcinoma in a series of patients undergoing surgical excision after an office biopsy of vulvar high-grade squamous intraepithelial lesion (VHSIL).
Methods: Two hundred and sixteen consecutive patients treated in a tertiary-level referral center for vulvar disease in north-western Italy were recruited. Patients' records were reviewed by trained personnel.
Radiol Med
October 2017
Unit of Radiology, IRCCS Policlinico San Donato, Via Morandi 30, San Donato Milanese, 20097, Milan, Italy.
This position paper, issued by ICBR/SIRM and GISMa, summarizes the evidence on DBT and provides recommendations for its use. In the screening setting, DBT in adjunct to digital mammography (DM) increased detection rate by 0.5-2.
View Article and Find Full Text PDFG Ital Dermatol Venereol
December 2019
Romagna Cancer Registry, Romagna Cancer Institute (IRST) IRCCS, Meldola, Forlì-Cesena, Italy.
Background: The epidemiologic trends of cutaneous melanoma are similar in several countries with a Western-type lifestyle, where there is a progressively increasing incidence and a low but not decreasing mortality - even increasing in selected cases, especially in the older age groups. Also in Tuscany there is a steady rise in the incidence with prevalence of in situ and invasive thin melanomas, with also an increase of thick melanomas. It is necessary to reduce the frequency of thick melanomas to reduce specific mortality.
View Article and Find Full Text PDFEur J Cancer
April 2017
ISPO - Cancer Research and Prevention Institute, Clinical Epidemiology, Florence 50141, Italy. Electronic address:
Background: The objective of this study was to evaluate if mammography screening attendance is associated with a reduction in late-stage breast cancer incidence.
Methods: The cohort included over 400,000 Italian women who were first invited to participate in regional screening programmes during the 1990s and were followed for breast cancer incidence for 13 years. We obtained individual data on their exposure to screening and correlated this with total and stage-specific breast cancer incidence.
Eur J Cancer Prev
January 2017
aRomagna - Cancer Registry, Romagna Cancer Institute (IRST) IRCCS, Meldola (FC) bTuscan Region Cancer Registry, Institute for Cancer Study and Prevention (ISPO) cMedical Oncology Unit, Oncological Department, Careggi Hospital, University of Florence, Florence, Italy dDepartment of Biostatistics, University Hospital of Lyon eUniversity of Lyon 1 fCNRS, UMR 5558, Biometrics and Evolutionary Biology Laboratory, Health-Biostatistics Group, Villeurbanne gLoire-Atlantique and Vendée Cancer Registry, Nantes, France.
Survival from breast cancer (BC) is influenced by the timeliness of diagnosis and appropriateness of treatment, and may constitute a measure of the global effectiveness of a healthcare system. As the healthcare systems of several European Latin countries have some similarities, the search for differences in cancer survival may provide interesting information on the efficacy of these systems. The SUDCAN study is a collaboration between the Group for Epidemiology and Cancer Registration in Latin language countries (GRELL) and EUROCARE.
View Article and Find Full Text PDFEur J Cancer Prev
January 2017
aRomagna Cancer Registry, Romagna Cancer Institute (IRST) IRCCS, Meldola, Forlì, Italy bNational Centre for Epidemiology, Surveillance and Health Promotion, ISS, Rome cDipartimento di Medicina Predittiva e per la Prevenzione, S.S.D. Epidemiologia Valutativa, Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy dDepartment of Biostatistics, University Hospital of Lyon eUniversity of Lyon, Lyon fUniversity of Lyon 1 gCNRS UMR 5558, Biometrics and Evolutionary Biology Laboratory (LBBE), BioMaths-Health Department, Health-Biostatistics Group, Villeurbanne hDepartment of Non-communicable Diseases and Injuries, French Institute for Public Health Surveillance (Invs), Sainte-Maurice iDigestive Cancer Registry of Burgundy, CHU de Dijon jINSERM U 866, University of Burgundy, Dijon, France.
The aim of the SUDCAN collaborative study was to compare the net survival from 15 cancers diagnosed in 2000-2004 in six European Latin countries and provide trends in net survival and dynamics of excess mortality rates up to 5 years after diagnosis from 1992 to 2004 in France, Italy, Spain, and Switzerland, and from 2000 to 2004 in Belgium and Portugal. This paper presents a detailed description of the data analyzed and quality indicators. Incident cases from Belgium, France, Italy, Portugal, Spain, and Switzerland were retrieved from 56 general or specialized population-based cancer registries that participated in the EUROCARE-5 database.
View Article and Find Full Text PDFESMO Open
August 2016
GSK Vaccines, Rixensart, Belgium; Celyad, Mont-Saint-Guibert, Rixensart, Belgium.
Purpose: The PRAME tumour antigen is expressed in several tumour types but in few normal adult tissues. A dose-escalation phase I/II study (NCT01149343) assessed the safety, immunogenicity and clinical activity of the PRAME immunotherapeutic (recombinant PRAME protein (recPRAME) with the AS15 immunostimulant) in patients with advanced melanoma. Here, we report the phase I dose-escalation study segment.
View Article and Find Full Text PDFInt J Cancer
January 2017
Romagna Cancer Registry, Romagna Cancer Institute (IRST) IRCCS, Meldola, Forlì, Italy.
Diagn Microbiol Infect Dis
November 2016
Romagna Cancer Registry, Romagna Cancer Institute (IRST) IRCCS, Meldola, Forlì, Italy. Electronic address:
Two-thirds of 152 patients treated for high-grade cervical disease, free of persistence/recurrence, and followed-up both with human papillomavirus (HPV) DNA testing and HPV genotyping cleared their high-risk HPV infection within 1year. Viral clearance continued at diminishing rates during the second and the third year, at the end of which it was virtually complete.
View Article and Find Full Text PDFRadiol Med
December 2016
Unit of Radiology, Research Hospital (IRCCS) Policlinico San Donato, Via Morandi 30, San Donato Milanese, 20097, Milan, Italy.
Women who were previously treated for breast cancer (BC) are an important particular subgroup of women at intermediate BC risk. Their breast follow-up should be planned taking in consideration a 1.0-1.
View Article and Find Full Text PDFJ Med Screen
March 2017
1 Romagna Cancer Registry, Romagna Cancer Institute (IRST) IRCCS, Meldola, Forlì, Italy.
Radiol Med
July 2016
Romagna Cancer Registry, Romagna Cancer Institute (IRST) IRCCS, Meldola, Forlì, Italy.
Purpose: Screening mammogram reading volume (SMRV) and total (screening and clinical) mammogram reading volume (TMRV) per year are strongly associated with the radiologist's diagnostic performance in breast cancer screening. The current article reports the prevalence and correlates of a SMRV and a TMRV ≥5000 among Italian breast screening radiologists.
Materials And Methods: A questionnaire survey was carried out in 2013-2014 by the Italian Group for Mammography Screening (GISMa).
Public Health
July 2016
Romagna Cancer Registry, Romagna Cancer Institute (IRST) IRCCS, Meldola, Forlì, Italy. Electronic address:
Biomed Res Int
April 2016
Romagna Cancer Registry, Romagna Cancer Institute (IRST) IRCCS, Via Piero Maroncelli 40, Meldola, 47014 Forlì, Italy.
Purpose: To report the accuracy of colposcopically directed biopsy in an internet-based colposcopy quality assurance programme in northern Italy.
Methods: A web application was made accessible on the website of the regional Administration. Fifty-nine colposcopists out of the registered 65 logged in, viewed a posted set of 50 digital colpophotographs, classified them for colposcopic impression and need for biopsy, and indicated the most appropriate site for biopsy with a left-button mouse click on the image.